Triad Isotopes

Triad Isotopes is a nuclear pharmacy company headquartered in Yardley, PA. The company employs 202 people and generates $100 million in annual revenue. Triad Isotopes operates a national network of over 50 locations, including four cyclotrons used to prepare PET doses. These facilities provide radiopharmaceuticals used by hospitals and nuclear medicine operators to diagnose and treat patients, primarily those with cardiac and cancer concerns. The company serves a wide range of healthcare providers, including Group Purchasing Organizations, regional healthcare systems, stand-alone clinics, and hospitals. Triad Isotopes differentiates itself with an open formulary approach, giving customers access to all available radiopharmaceuticals so they can select the formulas best suited to their patient needs. The company is also committed to advancing the field of Nuclear Medicine through education, research, publishing, and identifying innovative best practices. For more information, visit jdiri.com.